Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07662824 · ClinicalTrials.gov registry record · NA
Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT07662824: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT07662824 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07662824, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This clinical trial studies how well and how easy it is to use a device called Flyte in improving problems with bladder control (urinary incontinence) among endometrial and cervical cancer survivors who have undergone radiation therapy. Urinary incontinence is common after pelvic radiation therapy and can affect daily life and well-being. Access to in-person pelvic floor physical therapy can be limited. The Flyte device is designed for in-home use to deliver a series of mechanical vibrations at a specific frequency while the pelvic floor muscles are contracting and relaxing (i.e., normal, guided Kegel exercises). This treatment is called mechanotherapy. The Flyte device may improve urinary incontinence symptoms, as well as overall quality of life among endometrial and cervical cancer survivors who have undergone radiation therapy.
Interventions
- OTHER Questionnaire Administration
- OTHER Educational Intervention
- OTHER Interview
- OTHER Referral
- DEVICE Flyte Medical Device Usage and Evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2026-08-13 |
| Est. Completion | 2028-08-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07662824
The ClinicalTrials.gov registry entry for NCT07662824 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT07662824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07662824 about?
NCT07662824 is a clinical study titled "Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy". This clinical trial studies how well and how easy it is to use a device called Flyte in improving problems with bladder control (urinary incontinence) among endometrial and cervical cancer survivors who have undergone radiation therapy. Urinary incontinence is common after pelvic radiation therapy a...
What is the current status of trial NCT07662824?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2026-08-13. Estimated completion is 2028-08-13.
What interventions are being tested in trial NCT07662824?
The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER), Interview (OTHER), Referral (OTHER), Flyte Medical Device Usage and Evaluation (DEVICE).
Who is sponsoring clinical trial NCT07662824?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.